Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates

Clinical Neurology

Volumn 45, Issue 1, 2005, Pages 1-5

  Kashihara, Kenichi ^a   Ohno, Manabu ^a   Katsu, Yasuko ^a  

^a OKAYAMA KYOKUTO HOSPITAL   (Japan)

Author keywords

Delusion; Hallucination; Parkinson's disease; Psychosis; Risk factor

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGITATION; AKINESIA; ANXIETY DISORDER; ARTICLE; AUDITORY HALLUCINATION; BITE; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DELUSION; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; DYSKINESIA; DYSTONIA; ELECTROENCEPHALOGRAM; FRACTURE; HALLUCINATION; HAMILTON SCALE; HOSPITAL ADMISSION; HUMAN; LOW BACK PAIN; MANIA; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PHENOMENOLOGY; PNEUMONIA; PSYCHOSIS; RISK FACTOR; SEIZURE; SENSORY DYSFUNCTION; SEXUAL DYSFUNCTION; STEREOTYPY; TREMOR; VISUAL HALLUCINATION;

AGED; ANXIETY; CEREBRAL INFARCTION; DELUSIONS; DEPRESSION; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PNEUMONIA; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 13444278755     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aarsland D, Karlsen K: Neuropsychiatric aspects of Parkinson's disease. Curr Psychiatry Rep 1999; 1: 61-68
2. Goetz CG, Stebbins GT: Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993; 43: 2227-2229
3. Factor SA, Feustel PJ, Friedman JH, et al: Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003; 60: 1756-1761
4. Davis PC, Gray L, Albert M. et al: The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology 1992; 42: 1676-1680
5. Fazekas F, Barkhof F, Wahlund LO, et al: CT and MRI rating of white matter lesions. Cerebrovasc Dis 2002; 13 Suppl 2: 31-36
6. Sanchex-Ramos JR, Ortoll R, Paulson GW: Visual hallucinations associated with Parkinson disease. Arch Neurol 1996; 53: 1265-1268
7. Holroyd S, Currie L, Wooten GF: Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 64: 533-535
8. Fénelon G, Mahier F, Huon R. et al: Hallucinations in Parkinson's disease Prevalence, phenomenology and risk factors. Brain 2000; 123: 733-745
9. Barnes J, David AS: Visual hallucinations in Parkinson's disease: a review and phenomenological survey. N Neurol Neurosurg Psychoatry 2001; 70: 727-733
10. Factor SA, Molho ES, Podskalny GD, et al: Parkinson's disease: Drug-induced psychoatric states. In Advences in Neurology, ed by Weiner WJ, Lang AE, vol 65. Paven Press, New York. 1995, pp115-138
11. Aarsland D, Larsen JP, Cummings JL. et al: Prevalence and clinical correlates of psychotic symptoms in Parkinson's disease. A community-based study. Arch Neurol 1999; 56: 595-601
12. Walters Ech: Intrinsic and extrinsic psychosis in parkinson's disease. J Neurol 2001; 248 (suppl 3): III/22-III/27
13. Apaydin H, Ahlskog JE, Parisi JE. et al: Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002; 59: 102-112